V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016597 | 270009453 | 1.6 | 90 | Palliative (P) | 2013-05-13 | 2016-11-07 | Cisplatin +Fluorouracil (2 wk) | N | N | 270015944 | CISPLATIN + FLUOROURACIL |
| 270016598 | 270009455 | 1.8 | null | Adjuvant (A) | 2018-08-14 | 2018-08-21 | Capecitabine 35days + RT | 02 | Y | 270015946 | CAPECITABINE + RT |
| 270016599 | 270009455 | 1.67 | null | Neo-adjuvant (N) | 2013-10-24 | 2013-10-24 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015946 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016600 | 270009460 | 1.9 | 95 | Disease modification (D) | 2015-03-09 | 2015-03-17 | CHOP R | 02 | N | 270015957 | CHOP R |
| 270016601 | 270016938 | 1.57 | 75 | Palliative (P) | 2018-01-18 | 2018-01-30 | IRINOTECAN + Panitumumab + RALTITREXED | N | N | 270015962 | NOT MATCHED |
| 270016602 | 270014424 | 1.69 | 94 | Adjuvant (A) | 2015-10-29 | 2016-03-03 | CHLVPP | N | N | 270015965 | CHLVPP |
| 270016603 | 270009465 | 1.73 | 53.3 | Neo-adjuvant (N) | 2018-06-18 | 2018-07-27 | Escalated BEACOP Dac | N | N | 270015967 | NOT MATCHED |
| 270016604 | 270009465 | null | 69 | Palliative (P) | 2013-09-10 | 2013-09-24 | CAPECITABINE + IRINOTECAN | null | null | 270015967 | CAPECITABINE + IRINOTECAN |
| 270016605 | 270014426 | 1.74 | 80 | Curative (C) | null | 2017-03-04 | DHAP | null | null | 270015974 | DHAP |
| 270016606 | 270009467 | 1.74 | 60.2 | Palliative (P) | 2015-12-17 | 2016-01-20 | null | 2 | N | 270015974 | NOT MATCHED |
| 270016607 | 270014428 | 1.82 | 57.2 | Palliative (P) | 2015-09-03 | 2015-09-03 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015983 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016608 | 270009471 | 1.77 | 72.4 | Adjuvant (A) | 2015-02-12 | 2015-03-03 | CAPECITABINE + RT | N | N | 270015983 | CAPECITABINE + RT |
| 270016609 | 270009475 | 1.6 | 59 | Palliative (P) | 2016-03-31 | 2016-04-07 | CHLVPP | N | null | 270015990 | CHLVPP |
| 270016610 | 270009476 | 1.8 | 92 | Adjuvant (A) | 2017-08-31 | 2017-09-07 | Fluorouricil + Folonic Acid (MdG) | N | null | 270015993 | FLUOROURACIL |
| 270016611 | 270009478 | 1.62 | 106.5 | Not known (9) | 2014-03-09 | 2014-03-28 | CISPLATIN + FLUOROURACIL | null | null | 270016002 | CISPLATIN + FLUOROURACIL |
| 270016612 | 270009479 | null | 90.5 | Palliative (P) | 2014-10-18 | 2014-12-10 | null | 2 | N | 270016007 | NOT MATCHED |
| 270016613 | 270009480 | 1.55 | 57 | Curative (C) | 2015-12-29 | 2016-04-12 | CAPECITABINE + RT | N | N | 270016009 | CAPECITABINE + RT |
| 270016614 | 270009481 | null | 80 | null | 2016-07-21 | 2016-07-30 | Cisplatin +Fluorouracil (3 wk) | N | N | 270016013 | CISPLATIN + FLUOROURACIL |
| 270016615 | 270009483 | 1.66 | 95.2 | Palliative (P) | 2013-11-07 | 2013-12-27 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016016 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016616 | 270014438 | 1.81 | 90 | Palliative (P) | 2018-07-30 | 2018-08-05 | DHAP | null | null | 270016024 | DHAP |
| 270016617 | 270014439 | 1.59 | 64.1 | null | 2018-05-31 | 2018-06-29 | DHAP | 02 | null | 270016033 | DHAP |
| 270016618 | 270014439 | 1.57 | 79.8 | Curative (C) | 2017-05-20 | 2017-05-23 | CHLVPP | 02 | Y | 270016033 | CHLVPP |
| 270016619 | 270020082 | null | null | Curative (C) | 2014-11-11 | 2014-11-11 | CHLVPP | N | Y | 270016041 | CHLVPP |
| 270016620 | 270009489 | 1.7 | null | Curative (C) | 2013-09-25 | 2013-09-26 | CHOP R - 21 days | N | N | 270016062 | CHOP R |
| 270016621 | 270009491 | 1.75 | 72.1 | Palliative (P) | 2014-04-14 | 2016-11-10 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016074 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016622 | 270014443 | 1.83 | 77 | Curative (C) | 2015-05-20 | 2015-05-27 | CHLVPP | N | Y | 270016115 | CHLVPP |
| 270016623 | 270009497 | null | null | Neo-adjuvant (N) | 2015-01-24 | 2015-02-04 | CETUXIMAB + RT | 02 | N | 270016118 | CETUXIMAB + RT |
| 270016624 | 270009500 | 1.81 | 69 | Curative (C) | 2017-08-27 | 2017-08-29 | DHAP | N | N | 270016124 | DHAP |
| 270016625 | 270014446 | 1.73 | 80 | Not known (9) | null | 2017-09-22 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016125 | FLUOROURACIL |
| 270016626 | 270009503 | 1.72 | 85 | Palliative (P) | null | 2017-06-05 | Bevacizumab + Oxaliplatin +MdG | Y | N | 270016133 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016627 | 270009505 | 1.8 | 64.8 | Curative (C) | null | 2015-02-25 | CHLORAMBUCIL + Procarbazine + VINBLASTINE | 2 | N | 270016135 | NOT MATCHED |
| 270016628 | 270014449 | 1.77 | 106.5 | Palliative (P) | null | 2015-07-09 | Capecitabine (14 day) + Irinotecan | 02 | Y | 270016137 | CAPECITABINE + IRINOTECAN |
| 270016629 | 270018403 | 1.27 | 65.9 | Curative (C) | 2015-04-23 | 2015-05-16 | DHAP | N | N | 270016139 | DHAP |
| 270016630 | 270019223 | 1.8 | 74.3 | Palliative (P) | null | 2015-02-23 | CHLVPP | N | N | 270016149 | CHLVPP |
| 270016631 | 270009507 | 1.8 | 73 | Adjuvant (A) | 2013-08-18 | 2013-09-01 | FLUOROURACIL | N | Y | 270016150 | FLUOROURACIL |
| 270016632 | 270018404 | 1.88 | 43.4 | Adjuvant (A) | 2014-05-10 | 2015-05-18 | Capecitabine 35days + RT | N | Y | 270016155 | CAPECITABINE + RT |
| 270016633 | 270009509 | 1.67 | 64.3 | Curative (C) | 2013-11-07 | 2014-06-04 | CHLVPP | 02 | N | 270016159 | CHLVPP |
| 270016634 | 270014452 | 1.8 | 79.3 | Curative (C) | 2017-03-07 | 2017-04-05 | CHOP R | 2 | N | 270016180 | CHOP R |
| 270016635 | 270016959 | null | null | null | 2015-06-25 | 2015-09-17 | DHAP | null | null | 270016186 | DHAP |
| 270016637 | 270009517 | null | null | Disease modification (D) | 2015-01-12 | 2015-01-19 | CHLVPP | N | null | 270016209 | CHLVPP |
| 270016638 | 270009521 | 1.65 | 87 | Neo-adjuvant (N) | 2016-11-23 | 2016-11-25 | Fluorouracil + Folinic Acid Weekly | 2 | N | 270016217 | FLUOROURACIL |
| 270016639 | 270009522 | 1.6 | 76 | Neo-adjuvant (N) | 2016-08-11 | 2016-08-13 | Capecitabine 42days + RT | 02 | null | 270016222 | CAPECITABINE + RT |
| 270016640 | 270009525 | 1.65 | 68.6 | Adjuvant (A) | null | 2015-01-15 | CAPECITABINE + IRINOTECAN | 2 | null | 270016227 | CAPECITABINE + IRINOTECAN |
| 270016641 | 270009528 | 1.71 | null | Neo-adjuvant (N) | 2018-04-21 | 2018-04-29 | CAPECITABINE + RT | N | null | 270016230 | CAPECITABINE + RT |
| 270016642 | 270014458 | 1.92 | 49.9 | Disease modification (D) | 2016-10-08 | 2018-02-02 | Capecitabine (14 day) + Irinotecan | 2 | N | 270016243 | CAPECITABINE + IRINOTECAN |
| 270016643 | 270009533 | 1.6 | 88.1 | Palliative (P) | 2015-12-11 | 2016-02-04 | CHLVPP | N | N | 270016244 | CHLVPP |
| 270016644 | 270014459 | 1.72 | 46 | Palliative (P) | 2018-07-30 | 2018-12-24 | CHLVPP | 99 | null | 270016250 | CHLVPP |
| 270016645 | 270009541 | 1.69 | 95.4 | null | 2016-08-30 | 2016-09-11 | FLUOROURACIL | 02 | Y | 270016266 | FLUOROURACIL |
| 270016646 | 270009545 | 1.7 | 90 | Palliative (P) | 2016-02-22 | 2016-02-22 | Trifluridine + Tipiracil | N | N | 270016268 | TRIFLURIDINE + TIPIRACIL |
| 270016647 | 270014463 | 1.61 | 82.8 | Palliative (P) | 2010-11-30 | 2013-09-08 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270016270 | BEVACIZUMAB + OXALIPLATIN + MdG |